Abstract
This cross-sectional study assesses drug coverage, formulary restrictions, median retail prices, and annual out-of-pocket costs associated with commonly used insulin products across Medicare Part D plans.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Cross-Sectional Studies
-
Diabetes Mellitus, Type 2* / drug therapy
-
Diabetes Mellitus, Type 2* / economics
-
Drug Costs
-
Glycated Hemoglobin
-
Health Expenditures* / statistics & numerical data
-
Humans
-
Hypoglycemic Agents* / economics
-
Hypoglycemic Agents* / therapeutic use
-
Insurance, Pharmaceutical Services / economics
-
Medicare Part D* / economics
-
Sodium-Glucose Transporter 2 Inhibitors* / economics
-
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
-
United States
Substances
-
Glycated Hemoglobin
-
Hypoglycemic Agents
-
Sodium-Glucose Transporter 2 Inhibitors